Page last updated: 2024-08-05 12:25:35

tetrahydroxyflavanone

A hydroxyflavanone with atleast four hydroxy substituents.

ChEBI ID: 38742

Members (9)

MemberDefinitionRole
aromadedrinA tetrahydroxyflavanone having hydroxy groupa at the 3-, 4'-, 5- and 7-positions.(+)-dihydrokaempferol
astilbinA flavanone glycoside that is (+)-taxifolin substituted by a alpha-L-rhamnosyl moiety at position 3 via a glycosidic linkage.astilbin
eriodictyolA tetrahydroxyflavanone that is flavanone substituted by hydroxy groups at positions 5, 7, 3' and 4' respectively.eriodictyol
leachianone gA tetrahydroxyflavanone having the hydroxy groups at the 2'-, 4'-, 5- and 7-positions and a prenyl group at 8-position.leachianone G
neoastilbinA flavanone glycoside that is (-)-taxifolin substituted by a alpha-L-rhamnosyl moiety at position 3 via a glycosidic linkage.neoastilbin
nymphaeol cA tetrahydroxyflavanone that is (2S)-flavanone substituted by hydroxy group at positions 5, 7, 3' and 4', a geranyl group at position 2' and a prenyl group at position 6. Isolated from Macaranga tanarius and propolis collected in Okinawa, it exhibits radical scavenging activity.nymphaeol C
propolin cA tetrahydroxyflavanone that is (2S)-flavanone substituted by hydroxy group at positions 5, 7, 3' and 4' and a geranyl group at position 6. Isolated from Macaranga tanarius and propolis collected in Okinawa, it exhibits radical scavenging activity.nymphaeol A
sigmoidin aA tetrahydroxyflavanone that is (2S)-flavanone substituted by hydroxy groups at positions 5, 7, 3' and 4' and prenyl groups at positions 2' and 5'. Isolated from Erythrina sigmoidea, it exhibits anti-inflammatory and antioxidant activities.sigmoidin A
vexibinolA tetrahydroxyflavanone having a structure of naringenin bearing an additional hydroxyl substituent at position 2' as well as a (2R)-5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl (lavandulyl) substituent at position 8'.sophoraflavanone G

Research

Studies (467)

TimeframeStudies, Drugs in This Class (%)All Drugs %
pre-19905 (1.07)18.7374
1990's28 (6.00)18.2507
2000's111 (23.77)29.6817
2010's235 (50.32)24.3611
2020's88 (18.84)2.80

Study Types

Publication TypeStudies, Drugs in This Class (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews14 (2.76%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other493 (97.24%)84.16%